ES2125880T3 - Composiciones liofilizadas mejoradas de ifosfamida. - Google Patents
Composiciones liofilizadas mejoradas de ifosfamida.Info
- Publication number
- ES2125880T3 ES2125880T3 ES92118093T ES92118093T ES2125880T3 ES 2125880 T3 ES2125880 T3 ES 2125880T3 ES 92118093 T ES92118093 T ES 92118093T ES 92118093 T ES92118093 T ES 92118093T ES 2125880 T3 ES2125880 T3 ES 2125880T3
- Authority
- ES
- Spain
- Prior art keywords
- ifosfamide
- lyophilized compositions
- improved lyophilized
- improved
- mesna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical group ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 title abstract 2
- 229960001101 ifosfamide Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004202 carbamide Substances 0.000 abstract 1
- 230000018044 dehydration Effects 0.000 abstract 1
- 238000006297 dehydration reaction Methods 0.000 abstract 1
- 230000008014 freezing Effects 0.000 abstract 1
- 238000007710 freezing Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Materials For Medical Uses (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/781,436 US5227373A (en) | 1991-10-23 | 1991-10-23 | Lyophilized ifosfamide compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2125880T3 true ES2125880T3 (es) | 1999-03-16 |
Family
ID=25122737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES92118093T Expired - Lifetime ES2125880T3 (es) | 1991-10-23 | 1992-10-22 | Composiciones liofilizadas mejoradas de ifosfamida. |
Country Status (24)
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995007083A1 (en) * | 1993-09-10 | 1995-03-16 | F.H. Faulding & Co. Limited | Ifosfamide lyophilisate composition |
| US5789000A (en) * | 1994-11-14 | 1998-08-04 | Bionumerik Pharmaceuticals, Inc. | Sterile aqueous parenteral formulations of cis-diammine dichloro platinum |
| DE19529057B4 (de) * | 1995-08-08 | 2007-12-13 | Baxter Healthcare S.A. | Ifosfamid-Lyophilisat-Zubereitungen |
| KR100246757B1 (ko) | 1997-05-09 | 2000-03-15 | 윤종용 | 트랜스컨덕턴스 가변방법 및 회로와 그를 이용한 가변 대역 필터 및 가변 이득 증폭기 |
| DE19733305A1 (de) * | 1997-08-01 | 1999-02-04 | Asta Medica Ag | Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin |
| AU1555099A (en) * | 1997-10-13 | 1999-05-03 | Stada Arzneimittel A.G. | Liquid presentations of oxazaphosphorine-containing pharmaceutical products |
| US5972912A (en) * | 1998-12-17 | 1999-10-26 | S.P. Pharmaceuticals | Method for lyophilizing ifosfamide |
| CN1126547C (zh) * | 2000-07-19 | 2003-11-05 | 南京振中生物工程有限公司 | 香菇多糖冻干粉针剂及其制备方法 |
| US6613927B1 (en) | 2002-02-08 | 2003-09-02 | American Pharmaceutical Partners, Inc. | Sterile lyophilized ifosfamide and associated methods |
| PL205936B1 (pl) | 2002-02-22 | 2010-06-30 | Schering Corp | Farmaceutyczny preparat zawierający termozolomid oraz sposób jego wytwarzania |
| KR101037313B1 (ko) * | 2002-09-05 | 2011-05-26 | 바라트 쎄럼스 앤드 백신스 리미티드 | 메스나를 함유하는 안정한 액체 옥스아자포스포린 조성물 |
| DE60332385D1 (de) * | 2002-12-02 | 2010-06-10 | Bharat Serums & Vaccines Ltd | Ifosfamid-zusammensetzungen zur parenteralen verabreichung und verfahren für ihre herstellung |
| US7199111B2 (en) * | 2002-12-02 | 2007-04-03 | Bharat Serums & Vaccines Ltd. | Aqueous ifosfamide compositions for parenteral administration and a process for their preparations |
| DK1667655T3 (da) * | 2003-10-01 | 2011-10-24 | Baxter Int | Ny anvendelse, farmaceutiske præparater og en fremgangsmåde til deres fremstilling |
| AU2005317047A1 (en) * | 2004-11-05 | 2006-06-22 | Cephalon, Inc. | Cancer treatments |
| US8436190B2 (en) | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
| EP1973406B1 (en) | 2005-12-28 | 2014-03-12 | Advanced Bionutrition Corporation | A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form |
| US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
| EP2071917B1 (en) * | 2006-09-29 | 2012-11-21 | Infa S.A. | Packaging system for pharmaceutical compositions and kit for intravenous administration |
| WO2008076975A1 (en) | 2006-12-18 | 2008-06-26 | Advanced Bionutrition Corporation | A dry food product containing live probiotic |
| AU2008251921A1 (en) * | 2007-05-08 | 2008-11-20 | Merck Sharp & Dohme Corp. | Methods of treatment using intravenous formulations comprising temozolomide |
| AR072777A1 (es) | 2008-03-26 | 2010-09-22 | Cephalon Inc | Formas solidas de clorhidrato de bendamustina |
| EP2326306A1 (en) | 2008-09-25 | 2011-06-01 | Cephalon, Inc. | Liquid formulations of bendamustine |
| US8076366B2 (en) * | 2009-01-15 | 2011-12-13 | Cephalon, Inc. | Forms of bendamustine free base |
| CA2986751A1 (en) | 2009-03-27 | 2010-09-30 | Intervet International B.V. | Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
| DK2435554T3 (en) * | 2009-05-26 | 2017-10-30 | Advanced Bionutrition Corp | STABLE DRY POWDER COMPOSITION WITH BIOLOGICALLY ACTIVE MICRO-ORGANISMS AND / OR BIOACTIVE MATERIALS AND PROCEDURES FOR ITS PREPARATION |
| US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
| WO2011094469A2 (en) | 2010-01-28 | 2011-08-04 | Advanced Bionutrition Corporation | Dry glassy composition comprising a bioactive material |
| JP5727611B2 (ja) | 2010-08-13 | 2015-06-03 | アドバンスド バイオニュートリション コーポレイション | 生体物質用の乾燥貯蔵安定化組成物 |
| ES2750749T3 (es) | 2014-01-06 | 2020-03-27 | Auxin Surgery Sa | Composiciones de Mesna liofilizadas |
| US10342769B2 (en) | 2014-11-14 | 2019-07-09 | Navinta Iii Inc | Carmustine pharmaceutical composition |
| ES2881809T3 (es) | 2015-07-29 | 2021-11-30 | Advanced Bionutrition Corp | Composiciones probióticas secas estables para usos dietéticos especiales |
| JP6706988B2 (ja) * | 2016-07-20 | 2020-06-10 | 日本化薬株式会社 | ボルテゾミブを含有する医薬組成物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3732340A (en) * | 1966-07-11 | 1973-05-08 | Asta Werke Ag Chem Fab | N',o-propylene phosphoric acid ester diamides |
| US4537883A (en) * | 1982-11-12 | 1985-08-27 | Mead Johnson & Company | Lyophilized cyclophosphamide |
| ZA851062B (en) * | 1984-03-01 | 1985-11-27 | Asta Werke Ag Chem Fab | Salts of oxazaphosphorine derivatives and process for their production |
| DE3722043A1 (de) * | 1986-07-11 | 1988-01-14 | Asta Werke Ag Chem Fab | Loesungen von oxazaphosphorinen mit verbesserter stabilitaet und verfahren zu deren herstellung |
| NO873860L (no) * | 1986-10-31 | 1988-05-02 | Asta Pharma Ag | Ifosfamid-lyofilisat og fremgangsmaate til deres fremstilling. |
| ES2021771B3 (es) * | 1987-03-06 | 1991-11-16 | Asta Pharma Ag | Procedimiento para la obtencion de ifosfamida con propiedades mejoradas. |
| EP0334083B1 (de) * | 1988-03-19 | 1991-07-24 | ASTA Pharma Aktiengesellschaft | Ifosfamid-Mesna-Lyophilisat und Verfahren zu dessen Herstellung |
| US5036060A (en) * | 1988-07-25 | 1991-07-30 | Fujisawa Usa, Inc. | Cyclophosphamide |
-
1991
- 1991-10-23 US US07/781,436 patent/US5227373A/en not_active Expired - Lifetime
-
1992
- 1992-10-20 SK SK3176-92A patent/SK279869B6/sk not_active IP Right Cessation
- 1992-10-20 MY MYPI92001893A patent/MY109794A/en unknown
- 1992-10-20 ZA ZA928104A patent/ZA928104B/xx unknown
- 1992-10-20 NZ NZ244816A patent/NZ244816A/en not_active IP Right Cessation
- 1992-10-20 KR KR1019920019270A patent/KR100247161B1/ko not_active Expired - Fee Related
- 1992-10-20 CZ CS923176A patent/CZ282445B6/cs not_active IP Right Cessation
- 1992-10-21 CA CA002081061A patent/CA2081061A1/en not_active Abandoned
- 1992-10-21 TW TW081108396A patent/TW217987B/zh not_active IP Right Cessation
- 1992-10-21 CN CN92111646A patent/CN1046202C/zh not_active Expired - Fee Related
- 1992-10-21 AU AU27166/92A patent/AU658011B2/en not_active Ceased
- 1992-10-21 HU HU9203306A patent/HU221428B/hu not_active IP Right Cessation
- 1992-10-21 EG EG63992A patent/EG20114A/xx active
- 1992-10-21 IL IL10349692A patent/IL103496A/en not_active IP Right Cessation
- 1992-10-22 EP EP92118093A patent/EP0538858B1/en not_active Expired - Lifetime
- 1992-10-22 FI FI924797A patent/FI107701B/fi active
- 1992-10-22 DE DE69228105T patent/DE69228105T2/de not_active Expired - Lifetime
- 1992-10-22 RU RU92004463A patent/RU2106138C1/ru not_active IP Right Cessation
- 1992-10-22 DK DK92118093T patent/DK0538858T3/da active
- 1992-10-22 AT AT92118093T patent/ATE175354T1/de not_active IP Right Cessation
- 1992-10-22 JP JP32457092A patent/JP3576180B2/ja not_active Expired - Lifetime
- 1992-10-22 ES ES92118093T patent/ES2125880T3/es not_active Expired - Lifetime
- 1992-10-23 MX MX9206105A patent/MX9206105A/es unknown
-
1995
- 1995-06-20 HU HU95P/P00276P patent/HU211293A9/hu unknown
-
1999
- 1999-03-31 GR GR990400929T patent/GR3029835T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2125880T3 (es) | Composiciones liofilizadas mejoradas de ifosfamida. | |
| ES2125062T3 (es) | Produccion de tabletas divisibles. | |
| ES2155052T3 (es) | Suela correctora para zapatos, que utiliza un contorno mayor que el plano de estabilidad tecnico ideal. | |
| ES2102093T3 (es) | Procedimiento para la preparacion de inulina de cadena larga. | |
| DE69713887D1 (de) | Herstellung von verzweigten tensiden | |
| BR8903631A (pt) | Fonte de flavor termicamente liberavel,gerador de flavor e processo para fabricar um material contendo tabaco termicamente liberavel | |
| AR240832A1 (es) | Procedimiento para obtener una nueva modificacion cristalina del 3-amino-1-hidroxi-propan-1,1-difosfonato disodico. | |
| ES2026182T3 (es) | Un proceso para la produccion de un solido granular adecuado para su utilizacion como polvo detergente o un compuesto del mismo. | |
| AR059764A2 (es) | Proceso para preparar una composicion farmaceutica de ritonavir y composicion que se obtiene | |
| ES2044849T3 (es) | Un procedimiento para preparar un glicosido de flavona. | |
| AR022358A1 (es) | Una composicion de epo, un procedimiento para su obtencion, un preparado farmaceutico que la contiene y un procedimiento para aumentar la actividadespecifica de una composicion de epo | |
| ES8900007A1 (es) | Un metodo para producir normas orales frente a virus de hepatitis-b. | |
| ES2040394T3 (es) | Procedimiento para preparar un material liofilizado de ifosfamida y mesna. | |
| ES2076155T3 (es) | Compuestos de piperidinilo. | |
| ES2038639T3 (es) | Procedimiento para la obtencion de alfa-pirrolidonas. | |
| ES2006710A4 (es) | Proceso para producir nueva levadura y productos de inhibir moldes | |
| ES455621A1 (es) | Un procedimiento para la preparacion de meta-ariloxibenzal- dehidos. | |
| AR030735A1 (es) | Un procedimiento para la produccion de un extracto de champinon natural | |
| ES2065737T3 (es) | Derivados de acido mandelico substituidos como inhibidores de 5-lipoxigenasa. | |
| ES2135115T3 (es) | Procedimiento para la obtencion de arilcarbonatos. | |
| IT7822095A0 (it) | Procedimento per fabbricare perborato di sodio monoidrato, eprodotto ottenuto secondo il procedimento. | |
| ES2080898T3 (es) | Procedimiento para la preparacion de una ciclobutanona opticamente activa, un producto intermedio en la sintesis de un nucleosido de ciclobutano opticamente activo. | |
| ES2188012T3 (es) | Procedimiento para tratar productos a base de fruta o verdura con adicion de pectinmetilesterasa y pectina. | |
| ES2047456B1 (es) | Composicion para la obtencion de un producto cosmetico y productos similares. | |
| ES2165376T3 (es) | Procedimiento de moldeado de polipropileno sindiotactico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 538858 Country of ref document: ES |